United States: 2008 Physician Fee Schedule Regulations Include Anti-IDTF Rule Changes

The final rule, effective January 1, 2008, narrows the Stark Law in-office ancillary services exception in a manner that will disrupt a number of medical group practices’ diagnostic imaging and pathology arrangements.

The Centers for Medicare and Medicaid Services (CMS) have issued the final 2008 Medicare physician fee schedule (MPFS) rule, which will be published in the Federal Register on November 27, 2007. In our July 2007 White Paper regarding the proposed version of the MPFS rule, we focused on certain sections of the proposed rule other than the technical payment calculation issues (not addressed here). In particular, we noted that CMS was using this MPFS rulemaking as a vehicle for revisions to the Stark Law regulations, certain rules regarding reassignment and purchased services, and requirements applicable to independent diagnostic testing facilities (IDTFs). The status of these provisions under the final rule is discussed below.

Stark Law Proposals and Other Physician Self-Referral Proposals

In the final rule, CMS has decided not to finalize the proposed Stark Law revisions, except for the proposed anti-markup rule, which, as discussed below, has significant Stark Law ramifications. With respect to the MPFS Stark Law proposals, CMS stated:

given the number of physician self-referral proposals, the significance of the provisions both individually and in concert with each other, and the volume of public comments, we do not believe it is prudent to finalize any of the proposals in this rule (except for the proposal for anti-markup provisions for diagnostic tests, as discussed below in this section). Although we are not finalizing the proposed revisions to the other physician self-referral regulations in this final rule with comment period, we are confident that we have sufficient information, both from the commenters and our independent research, to finalize revisions to the physician self-referral regulations without the need for new proposals and additional public comment.

CMS has indicated that it does indeed intend to address all of the Stark Law topics covered in the proposed MPFS rule. Moreover, note that the Stark Law proposals in the MPFS rule are distinct from the Stark Law Phase III final rule, which was published in September 2007 and will be effective December 4, 2007 (except for application of the "stand in the shoes" rule to certain academic medical centers and integrated tax-exempt systems, which has been extended to December 4, 2008). The Phase III rule was summarized in our White Paper entitled CMS Publishes Phase III Stark Law Rule."

Big Changes to Diagnostic Anti-Markup Rule Undercut In-Office Exception

The final 2008 MPFS (effective January 1, 2008) expands substantially the scope of the long-standing prohibition on a physician practice marking up to the Medicare program the cost of a purchased diagnostic test ordered by the physician practice. In so doing, CMS effectively narrows the Stark in-office ancillary services exception in a manner that will disrupt a number of medical group practices’ diagnostic imaging and pathology arrangements. Further, in combination with CMS’s new prohibition on an IDTF sharing its facility with another Medicare supplier or provider, these amendments effectively prohibit most physician practices and imaging centers from sharing a diagnostic imaging facility, regardless of whether the sharing is accomplished through a shared expense, part-time block lease or other method.

Specific Changes

First, CMS extends the anti-markup rule to the professional component (interpretation) of the diagnostic test. Second, CMS defines a purchased diagnostic test or interpretation as a test or interpretation purchased from an "outside supplier," i.e., someone who is not an employee (full-time or part-time) of the billing practice, and who does not furnish the test or interpretation to the billing practice (or other supplier) pursuant to a permitted reassignment of Medicare benefits. If the billing practice purchases the technical component of the diagnostic test, the practice is limited to the lower of the Medicare fee schedule amount, the practice’s actual charge and the outside supplier’s "net charge" to the practice (i.e., the outside supplier’s actual charge net of any payment by the outsider supplier to the practice for the use of the practice’s space or equipment). Notably, since a contracted or leased technologist does not have an independent basis for billing Medicare for the diagnostic test pursuant to an assignment from the patient (i.e., is not an enrolled Medicare supplier), the technologist has no basis for reassigning the Medicare payment for the test to the billing practice. Accordingly, such a technologist is an "outside supplier," as defined in the rule. However, this begs the question whether contracting for or leasing a technologist amounts to the "purchase" of the "technical component" of the diagnostic test when the billing practice owns or has a long-term lease of the diagnostic equipment, a key part of the technical component. If so, is the billing practice limited to billing Medicare for the "net charge" of the technologist, and cannot count the practice’s own costs associated with the diagnostic equipment and supplies? Additional clarification from CMS on this point is needed, because the question of what constitutes the "purchase" of the "technical component" of a diagnostic test goes to the heart of whether and how the rule applies.

Finally, CMS has announced a second and completely novel application of the anti-markup rule that for many billing practices will make the question of whether the technical component of the test is "purchased" moot. A physician practice that orders a diagnostic test (professional or technical component) that is not purchased from an outside supplier is still prohibited from marking up the test to the Medicare program if the diagnostic test is "performed at a site other than the office of the billing physician . . . " "Office of the billing practice" is defined as space in which the physician practice provides "substantially the full range of patient care services" that the physician practice provides generally. The rule does not specify whether a part-time office can meet this location standard. Although we believe that one should be able to presume that a part-time office that meets the Stark in-office ancillary services ("in-office") exception’s definition of the "same building" can qualify, additional clarification on this point is needed.

Implications for Technical Component Billing

This rule change means that, in order to markup to the Medicare program the charge paid by the practice for the technical component of a diagnostic test, a billing practice will, at a minimum, need to locate the technologist and diagnostic testing equipment in the billing practice’s office suite where the practice regularly conducts patient office visits. Consequently, as a practical matter, this new location-based application of the anti-markup rule effectively amends the location test of the Stark in-office exception. In reliance on the Stark in-office exception, many physician practices today furnish and bill the Medicare program for the technical component of diagnostic imaging and pathology services performed in space in which the practices do not provide the full range of patient care services that the practices provide generally. This includes virtually every medical practice that is billing Medicare for the technical component of diagnostic imaging and pathology services in reliance on the "centralized building" approach to the Stark in-office exception. "Centralized building" means space owned or leased by the practice on a 24/7 exclusive use basis, and, as a practical matter, is not space where the practice conducts office visits or furnishes other patient care services. Based on this rule change, practices that are billing the Medicare program for the technical component of diagnostic testing furnished directly by the practice (i.e., not purchased) in reliance on the "centralized building" approach (to the Stark in-office exception), and that cannot relocate their imaging or pathology operations to meet this new location test, will now be limited to the lower of the Medicare fee schedule amount, the practice’s actual charge and the "net charge" for the test. Based on preamble statements by CMS, the practice cannot include any other direct or indirect costs in its calculation of the "net charge" for the test. Depending on the resulting effect on technical component revenues and margins, this rule change could eliminate the utility of the "centralized building" approach (to the Stark in-office exception) for these practices.

Moreover, even practices that have relied on the "same building" approach to the Stark in-office exception for their Medicare claims for the technical component of diagnostic imaging and pathology services will have to carefully assess the impact of the rule. The "same building" approach requires only that the practice have a full- or part-time office (as defined by regulation) in the same building where the diagnostic testing is performed, not the same space. Based on our inquiry to CMS, the new location-based application of the anti-markup rule is not limited to diagnostic testing performed in reliance on the "centralized building" approach (to the Stark in-office exception), and CMS interprets same "space" to mean the same office suite. Consequently, a practice’s diagnostic testing facility (e.g., MRI) located on a different floor or wing of the building (perhaps done to satisfy special state licensing or building code standards designed to minimize the radiation risk to employees and patients), would not satisfy this new location test for the anti-markup rule. In other words, CMS appears to require that the space where the diagnostic testing is performed be contiguous with and accessible from those areas of the practice’s office suite where the practice furnishes substantially the full-range of patient care services the practice provides generally. This is a new burden on practices that have for years relied on the current Stark law definition of "same building." CMS has effectively changed the "same building" test to a "same office suite" test.

Implications for Professional Component Billing

With respect to group practice billing for the professional component of diagnostic imaging and pathology services ordered by a group practice physician, such billing is done today on the basis of a permitted reassignment from a physician contractor or employee. Thus, under the amended anti-markup rule, such interpretations would not be purchased from an "outside supplier." Further, such interpretations are billed to Medicare in reliance on the physician services exception to the Stark prohibitions. Thus, if the interpretations are performed by physicians in the group practice who are contractors, the interpretations must be performed "in the group’s facilities." However, the term "group’s facilities" is not defined by the Stark regulations and, thus, is reasonably interpreted to include any practice site. If the interpretation is performed by an employee of the practice, the Stark physician services exception permits the interpretation to be performed at any location. Under the new location-based rule, however, an interpretation performed by either an employee or contractor of the practice will be subject to the anti-markup rule unless it is performed at a site where the practice provides substantially the full range of patient care services that the practice generally provides. This means, for example, that a practice that is billing on a reassignment basis for the professional interpretations of a contracted radiologist performed at an imaging facility located at a "centralized building" location of the practice will now be subject to the anti-markup rule.

Implications of the Unclarified "Net Charge" Concept

Since many arrangements for services that are considered to be purchased under the revised regulations do not involve a "charge" per se, CMS’ refusal to further define what constitutes the "net charge" in these situations leaves entities with significant operational and billing risks. For example, while some preamble discussion suggests that it may be acceptable to implement the requirement using a "net cost" analysis, since the regulatory language, however, refers to the supplier’s net charge to the billing entity not to the billing entity’s costs, such an approach may expose an entity to false claims investigation. As CMS explained in response to a comment regarding the difficulty or impossibility of determining a "net charge" in some common arrangements, if the entity cannot calculate an accurate "net charge," it can structure its arrangements so that the anti-markup provision does not apply. Unfortunately, unless CMS provides further guidance regarding this critical aspect of the rule, it may be necessary for many entities to (i) forgo revenue and require the supplier to bill for the component it provides, (ii) arrange to have the services furnished in the offices of the billing physician or supplier, (iii) change the method of payment to reflect an easily identifiable charge or (4) prepare a net cost analysis in good faith and take the risk of challenge down the road.

Implications for Shared Diagnostic Testing Arrangements

Finally, we note that this new location-based application of the anti-markup rule could effectively prohibit physician practices with offices in the same building from sharing a diagnostic imaging facility, whether the "sharing" takes the form of a part-time block lease, shared expense or other arrangement. Since it appears that the imaging facility must be contiguous to the office suite of the billing practice in order for the imaging site to be in "space" where the billing practice furnishes substantially the full-range of its patient care services, multiple practices sharing an imaging facility in the same building would have a difficult time meeting this standard. As discussed elsewhere in this On the Subject, an IDTF can no longer share space or equipment with, or lease or sublease its operations to, another Medicare provider or supplier. Thus, whatever shared diagnostic testing arrangements may survive this amended anti-markup rule may not include IDTFs.

Next Steps

In light of the January 1, 2008, effective date for these changes, physician practices with diagnostic imaging or pathology facilities that are not located in an office suite where the practice is providing substantially the full range of patient care services that the practice generally provides should immediately assess the effect of the amended anti-markup rule on their operations, including their arrangements for professional interpretations. This would include physician practices that are billing for diagnostic testing in reliance on the "same building" approach to the Stark in-office exception (including shared imaging arrangements), as well as practices billing in reliance on the "centralized building" approach.

IDTF Issues

CMS adopted essentially all of the key changes to the IDTF Medicare conditions of participation that it had proposed earlier this year. Although CMS did provide some clarifications and distinctions between the final MPFS rule and the proposed rule with respect to IDTF reporting requirements, liability insurance coverage and other standards, the IDTF industry will probably be most affected by the adoption of the IDTF sharing prohibition in 42 C.F.R. § 410.33(g)(15).

The new sharing prohibition provides that, with limited exceptions, an IDTF may not (i) share a practice location with another Medicare-enrolled individual or organization, (ii) lease or sublease its operations or its practice location to another Medicare-enrolled individual or organization, or (iii) share diagnostic testing equipment used in the initial diagnostic test with another Medicare-enrolled individual or organization. The prohibition does not apply to hospital-based and mobile IDTFs, nor does it prohibit the sharing of non-clinical space and staff (e.g., waiting rooms, receptionists and schedulers).

The sharing prohibition will likely require the restructuring or perhaps unwinding of many types of existing imaging arrangements, including block leasing and shared imaging arrangements, by January 1, 2008. Acknowledging that some IDTFs may need additional time to address these changes, CMS did delay the effective date of the sharing prohibition until January 1, 2009, but only for existing IDTFs that are sharing a practice location. This extension does not extend to the leasing or subleasing of an IDTF’s operations or location, including block leases or the sharing of equipment used in an initial diagnostic test. The practical effect of the final rule is to require the restructuring or unwinding of most IDTF shared imaging arrangements in a very short time.

Since the sharing prohibition is applicable only to IDTFs and to not other types of Medicare providers providing diagnostic services, many physician practices and radiology practices will likely continue to consider participating in block leasing and other shared imaging arrangements without the involvement of an IDTF, to the extent such arrangements are otherwise properly structured to comply with applicable federal and state health care laws. IDTFs that are currently engaged in shared imaging arrangements should have such arrangement promptly reviewed to determine the rights and obligations it may have. Material equipment leasing and financing documents that may have been executed in connection with such arrangement should also not be overlooked.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.